Show simple item record

dc.contributor.authorClegg, Stephanie M
dc.contributor.authorEiel, Emily S
dc.contributor.authorFine, Sara
dc.contributor.authorGafni, Rachel I
dc.contributor.authorMost, Mathew J
dc.date.accessioned2023-05-26T16:29:03Z
dc.date.available2023-05-26T16:29:03Z
dc.date.issued2023-04-12
dc.identifier.citationClegg SM, Eiel ES, Fine S, Gafni RI, Most MJ. Atypical Fragility Fractures due to Bony or Soft Tissue Phosphaturic Mesenchymal Tumors: A Report of Two Cases. Case Rep Orthop. 2023 Apr 12;2023:5614065. doi: 10.1155/2023/5614065. PMID: 37090040; PMCID: PMC10115527.en_US
dc.identifier.issn2090-6749
dc.identifier.doi10.1155/2023/5614065en_US
dc.identifier.pmid37090040
dc.identifier.urihttp://hdl.handle.net/20.500.14038/52130
dc.description.abstractIntroduction: Tumor-induced osteomalacia (TIO) is a rare paraneoplastic disorder where patients present with hypophosphatemia, chronic diffuse bone pain, and occasionally fractures. Benign phosphaturic mesenchymal tumors (PMT) are responsible for the TIO and are largely soft tissue tumors. Cases: Two male patients with TIO secondary to PMT were reported-one in the bony scapula and the other in the plantar foot soft tissue. The first case describes a 63-year-old Caucasian male, who sustained an intertrochanteric proximal femur stress fracture and approximately two years of diffuse bone pain and hypophosphatemia. Wide excision of a left scapula boney lesion resulted in immediate resolution of his electrolyte abnormalities and bone pain. Case 2 describes a 58-year-old male with four years of multifocal bone pain and atraumatic fractures. A 68Ga-DOTATATE-positron emission tomography/computed tomography (PET/CT) scan identified a soft tissue tumor in his plantar foot, which was ultimately excised. He also experienced near immediate resolution of his pain and no additional fractures. Conclusion: TIO is a rare condition presenting with chronic multifocal bone pain, stress fractures, and hypophosphatemia. These two cases highlight that the causative tumor may originate in soft tissue or bone. Furthermore, a high index of suspicion, along with fibroblast growth factor-23 testing and DOTATATE-PET/CT localization, can help with diagnosis and minimize treatment delays.en_US
dc.language.isoenen_US
dc.relation.ispartofCase Reports in Orthopedicsen_US
dc.relation.urlhttps://doi.org/10.1155/2023/5614065en_US
dc.rightsCopyright © 2023 Stephanie M. Clegg et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.en_US
dc.rightsAttribution 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.titleAtypical Fragility Fractures due to Bony or Soft Tissue Phosphaturic Mesenchymal Tumors: A Report of Two Casesen_US
dc.typeCase Reporten_US
dc.source.journaltitleCase reports in orthopedics
dc.source.volume2023
dc.source.beginpage5614065
dc.source.endpage
dc.source.countryUnited States
dc.identifier.journalCase reports in orthopedics
refterms.dateFOA2023-05-26T16:29:04Z
dc.contributor.departmentOrthopedics and Physical Rehabilitationen_US
dc.contributor.departmentPathologyen_US


Files in this item

Thumbnail
Name:
5614065.pdf
Size:
2.108Mb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record

Copyright © 2023 Stephanie M. Clegg et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is
properly cited.
Except where otherwise noted, this item's license is described as Copyright © 2023 Stephanie M. Clegg et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.